Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes
First Claim
Patent Images
1. A method of treating impaired glucose tolerance (IGT) in a patient in need thereof comprising administering an effective dosage of a long acting insulin.
5 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to a method of reducing cardiovascular morbidity and mortality in a prediabetic or Type 2 Diabetes patient population. The method comprises administering an effective dosage of a long acting insulin, preferably insulin glargine, to a prediabetic or Type 2 Diabetes patient.
-
Citations
48 Claims
- 1. A method of treating impaired glucose tolerance (IGT) in a patient in need thereof comprising administering an effective dosage of a long acting insulin.
- 8. A method of treating impaired fasting glucose (IFG) in a patient in need thereof comprising administering an effective dosage of a long acting insulin.
- 15. A method of treating early Type 2 diabetes in a patient in need thereof comprising administering an effective dosage of a long acting insulin.
- 22. A method of treating diabetic dyslipidemia in a Type 2 diabetes patient comprising administering an effective dosage of a long acting insulin.
- 29. A method of treating atherosclerosis in a patient diagnosed with a disease or condition selected from the group consisting of IFG, IGT, and early Type 2 diabetes, comprising administering an effective dosage of a long acting insulin.
- 34. A method of improving endothelial function in a patient diagnosed with a disease or condition selected from the group consisting of IFG, IGT, and early Type 2 diabetes, comprising administering an effective dosage of a long acting insulin.
- 39. A method of improving left ventricular diastolic and systolic function in a patient diagnosed with a disease or condition selected from the group consisting of IFG, IGT, and early Type 2 diabetes, comprising administering an effective dosage of a long acting insulin.
- 44. A method of reducing blood glucose levels in a patient diagnosed with a disease or condition selected from the group consisting of IFG, IGT, and early Type 2 diabetes, comprising administering an effective dosage of a long acting insulin.
Specification